Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy. (Abstract/Comunicazione in rivista)

Type

• Abstract/Comunicazione in rivista (Classe)
• Prodotto della ricerca (Classe)

Label

• Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy. (Abstract/Comunicazione in rivista) (literal)

Anno

• 1994-01-01T00:00:00+01:00 (literal)

Alternative label

• Lazzarino M, Morra E, Merante S, Bernasconi P, Corso A, Lisa A, Zei G, Bernasconi C. (1994)
  Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy.
  
  (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

• Lazzarino M, Morra E, Merante S, Bernasconi P, Corso A, Lisa A, Zei G, Bernasconi C. (literal)

Pagina inizio

• 171 (literal)

Pagina fine

• 171 (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

• 87 (literal)

Rivista

• British journal of haematology (Rivista)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo

• 1 (literal)

Note

• Abstract (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

• IGM-CNR; Istituto di Ematologia Un. Pavia e Divisione di Ematologia Istituto Scientifico San Matteo PV (literal)

Titolo

• Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy. (literal)

Prodotto di

• Biologia Computazionale (ME.P07.005.001) (Modulo)
• Institute of molecular genetics (IGM) (Istituto)

Autore CNR

• ANTONELLA LISA (Persona)

Insieme di parole chiave

• Keywords of "Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy." (Insieme di parole chiave)

Incoming links:

Prodotto

• Institute of molecular genetics (IGM) (Istituto)
• Biologia Computazionale (ME.P07.005.001) (Modulo)

Autore CNR di

• ANTONELLA LISA (Persona)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• British journal of haematology (Rivista)

Insieme di parole chiave di

• Keywords of "Response to different treatments in chronic myelogenous leukemia (CML) according to risk assessment at diagnosis: survival advantage with interferon alfa therapy." (Insieme di parole chiave)